Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Published October 15, 2025 · Recall initiated: September 26, 2025
Summary
FDA records drug Class II recall D-0008-2026, published October 15, 2025 and initiated September 26, 2025. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 571 vials; Lot: Lot # K250048. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
What to do
Voluntary: Firm initiated · Letter
Get an email if SUCCINYLCHOLINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SUCCINYLCHOLINE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Nationwide within the USA.
- UPC
- 0343598666259
- Lot
- Lot # K250048
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANorgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3October 15, 2025
- FDAMajor ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 50 Tablets (5x10) blister package, Rx Only, PackagedOctober 15, 2025
- FDALevothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for AccordOctober 15, 2025
- FDAMajor ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister package, Rx Only, PackagedOctober 15, 2025
- FDAAFCO, Hand Sanitizer (Isopropyl Alcohol-Based, Product 5515), Manufactured by: AFCO, 550 Development Avenue,October 15, 2025
- FDAMajor ChlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 Tablets, (10x10) blister package, Rx Only,October 15, 2025
Questions about this recall
Was Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25 recalled?
Yes. FDA published recall D-0008-2026 on October 15, 2025. Reported hazard: Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SUCCINYLCHOLINE. UPC: 0343598666259.